Eli Lilly said on Monday
that it will acquire a manufacturing facility from Nexus
Pharmaceuticals to produce injectable medicines. Lilly expects production at the facility based in.
Eli Lilly expands its global manufacturing network with FDA-approved facility acquisition in Pleasant Prairie, Wisconsin. Boosting production to meet growing demand for medicines, including GLP-1 drugs.
On Monday, Eli Lilly and Company LLY agreed to acquire a manufacturing facility from Nexus Pharmaceuticals. The deal terms were not disclosed. The acquisition…